Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Accumen Launches MyBloodHealth®, a Virtual Anemia Management Software Solution for the Perioperative Patient

    Sep 15, 2020, 15:50 PM by Michael Croft
    PHOENIX, AZ - Sep 15, 2020 - Accumen Inc. is helping healthcare get better, faster. Today the company launched its first software-as-a-service (SaaS) solution, MyBloodHealth®, a hospital-based telehealth anemia management program with both perioperative and comprehensive blood management options
    Full story
  • CANARIE Selects and Funds CanDIG Project to make Research Clinical Data FAIRer

    Sep 15, 2020, 11:18 AM by Michael Croft
    TORONTO, ON, CANADA - Sep 15, 2020 -  With advances in imaging technologies, new wearable health devices, mobile devices allowing patients to provide survey responses everywhere, and increasingly integrated electronic health records, health data consented for advancing biomedical research has never been more plentiful – or complex
    Full story
  • VAST Data Launches LightSpeed Storage Architecture

    Sep 15, 2020, 11:15 AM by Michael Croft
    Bio-IT World VAST Data has launched its next generation storage architecture, LightSpeed, which combines the light-touch of VAST’s simple NAS appliance experience with leadership-class performance for GPU-based and AI Processor-based computing, taking the guesswork and configuration out of scaling up AI infrastructure.
    Full story
  • Adventist Health Enhances Online Access for Both New and Existing Patients with Kyruus and Cerner Collaboration

    Sep 15, 2020, 09:55 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Sep 15, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and Cerner Corporation, a global healthcare technology company, today announced that Adventist Health, a faith-based, nonprofit integrated health system serving the West Coast and Hawaii, has enhanced its digital consumer access experience with integrated technology solutions from the two companies
    Full story
  • Absolute Antibody Adds SeqPack™ Hybridoma Preservation Kit to Antibody Sequencing Service

    Sep 15, 2020, 09:42 AM by Michael Croft
    REDCAR, UNITED KINGDOM - Sep 15, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of the SeqPack™ Hybridoma Preservation Kit, which streamlines the sample submission process for hybridoma sequencing customers worldwide
    Full story
  • CATO SMS ACQUIRES ARRAY BIOSTATISTICS

    Sep 15, 2020, 06:16 AM by Michael Croft
    CARY, NC - Sep 15, 2020 - For Immediate ReleaseCATO SMS ACQUIRES ARRAY BIOSTATISTICSGlobal Provider Expands Specialized Clinical Research Offering with Enhanced Biostatistical ServicesCARY, Nx
    Full story
  • Profacgen Provides Data Analysis Service for Biological Discovery

    Sep 15, 2020, 03:50 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Sep 15, 2020 - Profacgen, a state-of-the-art protein service provider based in New York, established its own bioinformatics platform, which has emerged as a very sophisticated scientific infrastructure for bioinformatics involving computational facilities, to help explore, understand and analyze complex biological data in various biotechnological programs and projects
    Full story
  • HiFiBiO Therapeutics Announces a Global Strategic Partnership with ABL Bio for the Co-Development of a SARS-CoV-2 Neutralizing Antibody

    Sep 14, 2020, 10:25 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Sep 14, 2020 - HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today announced a partnership agreement with South Korea-based ABL Bio to advance HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment of COVID-19 patients
    Full story
  • WEP Clinical joins with Wren Healthcare to provide home healthcare services

    Sep 14, 2020, 09:35 AM by Michael Croft
    LONDON, UNITED KINGDOM - Sep 14, 2020 - WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU
    Full story
  • Check4Cancer launches online service to provide fast cancer screening as thousands of people go untested in the Covid-19 pandemic

    Sep 14, 2020, 05:48 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Sep 14, 2020 - Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing together all of its cancer services onto one platform
    Full story
  • Follow the Money: Alzheimer’s Meds, Single Cell Multi-Omics Technology

    Sep 14, 2020, 01:25 AM by Michael Croft
    Bio-IT World | NIH contracts to explore radiation countermeasures, Alzheimer’s medication, and convalescent plasma, Mission Bio gets $70M for single cell multi-omics technology, and more.
    Full story
  • No Cytokine Storm, ‘Bursty’ Disease Spread: Biomarkers For Elevated Risk: COVID-19 Updates

    Sep 11, 2020, 06:20 AM by Michael Croft
    Bio-IT World  | Japanese researchers argue there is no cytokine storm, computer-designed protective proteins, ELISA test for antibodies, COVID-19’s impact on Black and Hispanic communities, a “burstier” model of disease spread, and new biomarkers for elevated risk. Plus, the International Vaccine Institute preps with Gates money, 3M funds vaccine researcher, and more.
    Full story
  • SciBite launches state-of-the-art AI platform for Life Sciences organisations

    Sep 11, 2020, 06:08 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Sep 11, 2020 - SciBite, the award-winning semantic technology company, today announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning models alongside semantic technologies to unlock insights into Life Sciences data
    Full story
  • Positive Technologies: Vulnerabilities in PAN-OS could threaten internal networks security

    Sep 10, 2020, 13:05 PM by Michael Croft
    FRAMINGHAM, MA, UNITED STATES - Sep 9, 2020 - Palo Alto Networks remediated vulnerabilities in PAN-OS (operating systems version 8.1 or later), which is used by Palo Alto Networks next-generation firewalls (NGFW)
    Full story
  • Theratechnologies to Develop Tesamorelin for the Treatment of NASH in the General Population

    Sep 10, 2020, 10:20 AM by Michael Croft
    MONTREAL, QC, CANADA - Sep 10, 2020 - Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it plans to pursue Phase 3 clinical development of tesamorelin for the treatment of Non-Alcoholic Steatohepatitis (NASH) in the general population
    Full story
  • Salaso Health’s telemedicine and live exercise platform enable US healthcare teams to stay safely connected with COVID-19 patients

    Sep 10, 2020, 10:04 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Sep 10, 2020 - In the current pandemic environment, face-to-face physical therapy visits are less viable due to increasing demands on the healthcare system, as well as the enactment of stay-at-home measures and the reticence of patients particularly those from at-risk groups to visit a clinic or hospital setting
    Full story
  • Peer-reviewed Study by Optibrium Demonstrates the Value of Deep Learning for Imputation of Drug Discovery Data

    Sep 10, 2020, 06:54 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Sep 9, 2020 - Optibrium™, leading providers of software and services for drug discovery, today announced a peer-reviewed publication, ‘Practical Applications of Deep Learning to Impute Heterogeneous Drug Discovery Data’, in the Journal of Chemical Information and Modeling [1]
    Full story
  • Dotmatics introduces eln.online to support research start-ups

    Sep 10, 2020, 06:49 AM by Michael Croft
    BISHOP'S STORTFORD, UNITED KINGDOM - Sep 9, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of eln
    Full story
  • Phosplatin Therapeutics Announces Two Leadership Appointments

    Sep 9, 2020, 14:39 PM by Michael Croft
    NEW YORK, NY - Sep 9, 2020 - Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the addition to its growing team of Joseph F
    Full story
  • MDI Biological Laboratory Scientists Decipher Role of a Stress Response Gene

    Sep 9, 2020, 13:27 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Sep 9, 2020 - Scientists have long known that chronic stress experienced early in life, or even chronic prenatal exposure to maternal stress hormones in the womb, can shorten lifespan and contribute to age-related chronic diseases like arthritis, asthma, cancer, cardiovascular disease, diabetes, heart disease and even mental illness later in life -- long after the source of stress has been removed
    Full story
  • «
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198 (current)
  • 199
  • 200
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy